Published in Obesity and Diabetes Week, March 7th, 2005
The 3-month period ended December 31, 2004, represents a transition quarter for the company as it has changed its fiscal year-end from September 30th to December 31st, to align its operating cycle with that of its alliance partners and its industry sector.
The company reported a net loss of $48.4 million (or $1.02 per share) for the 3 months ended December 31, 2004, compared with a net loss of $40.1 million (or $1.03 per share) in the comparable prior year period. On a non-GAAP basis, excluding certain charges and adjustments,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week